Related references
Note: Only part of the references are listed.Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study
Walid Saliba et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Novel composite score to predict atrial Fibrillation in acute stroke patients AF predicting score in acute stroke
Woo-Keun Seo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The role of CHADS2 and CHA2DS2-VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study
W. Saliba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
A1c value for diabetes diagnosis in subjects with established cardiovascular disease
A. Luzi et al.
ACTA DIABETOLOGICA (2015)
Is diabetes a hypercoagulable state? A critical appraisal
Fulvio Pomero et al.
ACTA DIABETOLOGICA (2015)
CHA(2)DS(2)-VASc scores predict mortality after hospitalization for atrial fibrillation
Sirin Apiyasawat et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
Line Melgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The CHA(2)DS(2)VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation
Kyung Hwan Kim et al.
JOURNAL OF CARDIOLOGY (2015)
Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation
Tomasz Podolecki et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study
Ranjit Mohan Anjana et al.
ACTA DIABETOLOGICA (2015)
Coronary artery disease as an independent predictor of survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy
Dominik Bergis et al.
ACTA DIABETOLOGICA (2014)
Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study
Petter Bjornstad et al.
ACTA DIABETOLOGICA (2014)
Roles of the CHADS(2) and CHA(2)DS(2)-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke
Kui-Kai Lau et al.
CARDIOLOGY JOURNAL (2014)
Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores
L. Brent Mitchell et al.
HEART (2014)
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts
Jonathan P. Piccini et al.
CIRCULATION (2013)
CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation
George Ntaios et al.
NEUROLOGY (2013)
Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction
Sergio Barra et al.
THROMBOSIS RESEARCH (2013)
Role of the CHADS2 Score in Acute Coronary Syndromes Risk of Subsequent Death or Stroke in Patients With and Without Atrial Fibrillation
Dritan Poci et al.
CHEST (2012)
A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study)
Alanna M. Chamberlain et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI
David D. McManus et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Increases in Cerebral Atherosclerosis According to CHADS2 Scores in Patients With Stroke With Nonvalvular Atrial Fibrillation
Young Dae Kim et al.
STROKE (2011)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
Renate B. Schnabel et al.
LANCET (2009)
Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2007)
ESC guidelines for percutaneous coronary interventions: reply
S Silber
EUROPEAN HEART JOURNAL (2005)
A validated prediction model for all forms of acute coronary syndrome - Estimating the risk of 6-month postdischarge death in an international registry
KA Eagle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Application of the TIMI risk score for ST-Elevation MI in the National Registry of Myocardial Infarction 3
DA Morrow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
